Acute and chronic psychostimulant treatment modulates the diurnal rhythm activity pattern of WKY female adolescent rats Cathleen G. JonesPamela B. YangNachum Dafny Translational Neurosciences - Original Article 31 January 2014 Pages: 457 - 468
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS) Marta Łukaszewicz-ZającBarbara MroczkoPiotr Lewczuk Translational Neurosciences - Review article 24 December 2013 Pages: 469 - 477
Global signaling effects of a schizophrenia-associated missense mutation in neuregulin 1: an exploratory study using whole genome and novel kinome approaches Ketan K. MarballiRobert E. McCullumsmithConsuelo Walss-Bass Translational Neurosciences - Original Article 01 January 2014 Pages: 479 - 490
HTRA2 variations in Taiwanese Parkinson’s disease Chiung-Mei ChenChun-Hsien WuYih-Ru Wu Neurology and Preclinical Neurological Studies - Original Article 12 December 2013 Pages: 491 - 498
A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson’s disease Stefano CalzettiMonica AngeliniMatteo Goldoni Neurology and Preclinical Neurological Studies - Original Article 20 December 2013 Pages: 499 - 506
Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival Dusan RoncevicJose-Alberto PalmaHoracio Kaufmann Neurology and Preclinical Neurological Studies - Original Article 15 December 2013 Pages: 507 - 512
Very early reduction in efficacy of botulinum toxin therapy for cervical dystonia in patients with subsequent secondary treatment failure: a retrospective analysis Harald HefterConstanze SpiessDietmar Rosenthal Neurology and Preclinical Neurological Studies - Original Article Open access 06 December 2013 Pages: 513 - 519
Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry Axel SchrammJean-Pierre NdayisabaJoerg Wissel Neurology and Preclinical Neurological Studies - Original Article 10 January 2014 Pages: 521 - 530
Botulinum toxin in myotonia congenita: it does not help against rigidity and pain Dirk DresslerFereshte Adib Saberi Neurology and Preclinical Neurological Studies - Short communication 20 December 2013 Pages: 531 - 532
Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer’s disease Virginia AndreoliElvira Valeria De MarcoAntonio Gambardella Neurology and Preclinical Neurological Studies - Original Article 01 December 2013 Pages: 533 - 542
ERK inhibition with PD184161 mitigates brain damage in a mouse model of stroke Amadeus GladbachJanet van EerselLars M. Ittner Neurology and Preclinical Neurological Studies - Short communication 14 December 2013 Pages: 543 - 547
Myotonia in DNM2-related centronuclear myopathy Ron DabbyMenachem SadehEsther Leshinsky-Silver Neurology and Preclinical Neurological Studies - Original Article 24 December 2013 Pages: 549 - 553
Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region B. FilipovićI. MatakZ. Lacković Neurology and Preclinical Neurological Studies - Original Article 24 December 2013 Pages: 555 - 563